期刊文献+

^99Tc^m-HYNIC-Annexin V动脉粥样硬化显像的实验研究 被引量:3

Research on the ^99Tc^m-HYNIC-Annexin V scintigraphy of rabbit atherosclerotic lesions
原文传递
导出
摘要 目的探讨^99Tc^m-联肼尼克酰胺(HYNIC)-膜联蛋白V(Annexin V)显像检测兔动脉粥样硬化(AS)病变的价值。方法5只雄性日本大耳白兔通过免疫损伤血管和12周高脂饮食制备成AS模型(实验组),白兔耳缘静脉按体质量注射^99Tc^m-HYNIC-Annexin V 37MBq/kg,分别行活体和离体血管的^99Tc^m-HYNIC—Annexin V显像。5只未经特殊处理的同种白兔行活体显像作为对照。对实验组兔的主动脉分段后,测定各片段质量和放射性计数,并进行病理学和免疫组织化学检查。采用SPSS 13.0软件对数据进行统计学处理。结果显像剂注射后2h,实验组兔主动脉可见放射性摄取达峰值,而对照组未见明显的放射性摄取,前者靶/非靶(T/NT)比值(2.70±0.26)明显高于后者(1.30±0.13,t=1.99,P〈0.05)。实验组兔的主动脉血管斑块片段放射性摄取(每克组织百分注射剂量率,%ID/g)为(0.075±0.016)%ID/g,明显高于非斑块血管片段[(0.035±0.013)%ID/g,前者是后者的(4.55±0.99)倍,t=4.77,P〈0.001];两者的凋亡细胞指数(AI)分别为(40.53±14.94)%和(11.90±7.09)%,差异具有统计学意义(t=2.54,P〈0.01)。所有血管片段的放射性摄取(%ID/g值)与AI呈正相关(r=0.98,P〈0.001)。结论^99Tc^m-HYNIC-Annexin V可以无创性地检测AS斑块的凋亡。 Objective The aim of this study was to investigate the value of ^99Tc^m-hydrazino-nictinamide (HYNIC)-Annexin V scintigraphy in the detection of rabbit atherosclerotic lesions. Methods Five Japanese male rabbits, which received immune injury of arteries combined with 12 weeks of high fat diet, underwent scintigraphy after injection of 37 MBq/kg ^99Tc^m-HYNIC-Annexin V. Another 5 rabbits were studied as control. The aortas of the atherosclerotic rabbits were explanted for ex vivo imaging and then cut into segments for radioactive detection and histological characterization of the lesions. SPSS 13.0 was used to analyse the data. Results In compared with the controls, study groups showed significantly high uptake of ^99Tc^m-HYNIC-Annexin V (2.70 ± 0.26 vs 1.30 ± 0.13, t = 1.99, P 〈 0.05) at 2 h after injection. Moreover, higher ^99Tc^m-HYNIC-Annexin V ratio [ (4. 55 ±0.99)-fold], higher activity (the percentage of injected dose per gram, % ID/g) at plaque vs non-plaque segments [ (0.075 ±0.01 ) % ID/g vs (0.035±0.01) %ID/g, t =4.77, P〈0.001] and high apoptotic index [AI, (40.53 ±14.94)% vs (11.90 ± 7.09) %, t =2. 54, P 〈0.01 ] were also noted. Furthermore, positive correlation was noted between % ID/g and AI (r =0.98, P 〈0.001 ). Conclusion ^99Tc^m-HYNIC-Annexin V scintigraphy has a potential value in identifying the apoptosis of atherosclerotic plaques in rabbit models.
出处 《中华核医学杂志》 CAS CSCD 北大核心 2008年第3期206-208,共3页 Chinese Journal of Nuclear Medicine
基金 国家自然科学基金(30271439)
关键词 动脉粥样硬化 细胞凋亡 膜联蛋白 V 放射性核素显像 Atherosclerosis Apoptosis Annexin V Radionuclide imaging Rabbits
  • 相关文献

参考文献11

  • 1兰晓莉,张永学,安锐,高再荣,曹国祥.~99TC^m-HYNIC-Annexin V的制备及其在健康小鼠体内的分布[J].中华核医学杂志,2005,25(6):344-346. 被引量:9
  • 2Best PJ, Hasdai D, Sangiorgi G, et al. Apoptosis. Basic concepts and implications in coronary artery disease. Arterioscler Thromb Vasc Biol, 1999, 19: 14-22.
  • 3Fadok VA, de Cathelineau A, Daleke DL, et al. Loss of phospholipid asymmetry and surface exposure of phosphatidylserine is required for phagocytosis of apoptotic cells by macrophages and fibreblasts. J Biol Chem, 2001, 276: 1071-1077.
  • 4Lahorte CM, Vanderheyden JL, Steinmetz N, et al. Apoptosis-detecting radioligands : current state of the art and future perspectives. Eur J Nucl Med Mol Imaging, 2004, 31 : 887-919.
  • 5Tait JF, Brown DS, Gibson DF, et al. Development and characterization of annexin V mutants with endogenous chelation sites for ^99Tc^m. Bioconjug Chem, 2000, 11 : 918-925.
  • 6Russell J, O'Donoghue JA, Finn R, et al. Iodination of annexin V for imaging apoptosis. J Nucl Med, 2002, 43: 671-677.
  • 7Lahorte CM, van de Wiele C, Bather K, et al. Biodistribution and dosimetry study of ^123I-rh-annexin V in mice and humans. Nucl Med Commun, 2003, 24: 871-880.
  • 8Zijlstra S, Gunawan J, Burchert W. Synthesis and evaluation of a ^18F-labelled recombinant annexin-V derivative, for identification and quantification of apoptotic cells with PET. Appl Radiat Isot, 2003, 58 : 201-207.
  • 9Johnson LL, Schofield L, Donahay T, et al.^ 99Tc^m-annexin V imaging for in vivo detection of atherosclerotic lesions in porcine coronary arteries. J Nucl Med, 2005, 46: 1186-1193.
  • 10Isner JM, Kearney M, Bortman S, et al. Apoptosis in human atherosclerosis and restenosis. Circulation, 1995, 91 : 2703-2711.

二级参考文献11

  • 1Takei T,Kuge Y,Zhao S,et al.Time course of apoptotic tumor response after a single dose of chemotherapy:comparison with 99TcmAnnexin V uptake and histologic findings in an experimental model.JNucl Med,2004,45:2083-2087.
  • 2Kartachova M,Haas RL,Olmos RA,et al.In vivo imaging of apoptosis by ^99Tc^m-Annexin V scintigraphy:visual analysis in relation to treatment response.Radiother Oncol,2004,72:333-339.
  • 3Kemerink GJ,Liem IH,Hofstra L,et al.Patient dosimetry of intravenously administered ^99Tc^m-Annexin V.J Nucl Med,2001,42:382-387.
  • 4Kemerink GJ,Boersma HH,Thimister PWL,et al.Biodistribution and dosimetry of ^99Tc^m-BTAP-Annexin V in humans.Eur J Nucl Med Mol Imaging,2001,28:1373-1378.
  • 5Purohit A,Liu S,Casebier D,et al.Phosphine-containing HYNICderivatives as potential bifunctional chelators for ^99Tc^m labeling of small biomolecules.Bioconjug Chem,2003,14:720-727.
  • 6Verbeke K,Kieffer D,Vanderheyden JL,et al.Optimization of the preparation of ^99Tc^m labeled HYNIC-derivatized Annexin V for human use.Nucl Med Biol,2003,30:771-778.
  • 7Blankenberg FG,Katsikis PD,Tait JF,et al.Imaging of apoptosis(programmed cell death)with ^99Tc^m-Annexin V.J Nucl Med,1999,40:184-191.
  • 8Kemerink GJ,Liu X,Kieffer D,et al.Safety,biodistribution,and dosimetry of ^99Tc^m-HYNIC-Annexin V,a novel human recombinant Annexin V for human application.J Nucl Med,2003,44:947-952.
  • 9Blankenberg FG,Tait J,Ohtsuki K,et al.Apoptosis:the importance of nuclear medicine.Nucl Med C ommun,2000,21:241-250.
  • 10Abrams MJ,Juweid M,Tenkate CI,et al.^99Tc^m-human polyclonal IgG radiolabeled via the hydrazine nicotinamide derivative for imaging focal sites of infection in rats.J Nucl Med,1990,31:2022-2028.

共引文献8

同被引文献69

  • 1王全师,陈宇,吴春山,张益金,刘德宣.^(99m)Tc-LDL显像检测实验性动脉粥样硬化斑块[J].中华核医学杂志,1996,16(4):247-249. 被引量:3
  • 2Reed JC. Apoptosis-based therapies[J].Nature Reviews Drug Discovery,2002.111-121.doi:10.1038/nrd726.
  • 3Reshef A,Shirvan A,Akselrod-Ballin A. Small-molecule biomarkers for clinical PET imaging of apoptosis[J].Journal of Nuclear Medicine,2010.837-840.doi:10.2967/jnumed.109.063917.
  • 4Zhou D,Chu W,Rothfuss J. Synthesis,radiolabeling,and in vivo evaluation of an 18F-labeled isatin analog for imaging caspase-3 activation in apoptosis[J].Bioorganic and Medicinal Chemistry Letters,2006.5041-5046.
  • 5Smith G,Glaser M,Perumal M. Design,synthesis,and biological characterization of a caspase 3/7 selective isatin labeled with 2-[18 F]fluoroethylazide[J].Journal of Medicinal Chemistry,2008.8057-8067.
  • 6Podichetty AK,Wagner S,Schr(o)er S. Fluorinated isatin derivatives.Part 2.New N-substituted 5-pyrrolidinylsulfonyl isatins as potential tools for molecular imaging of caspases in apoptosis[J].Journal of Medicinal Chemistry,2009,(11):3484-3495.doi:10.1021/jm8015014.
  • 7Chen DL,Zhou D,Chu W. Comparison of radiolabeled isatin analogs for imaging apoptosis with positron emission tomography[J].Nuclear Medicine and Biology,2009.651-658.
  • 8Mittl PR,Di Marco S,Krebs JF. Structure of recombinant human CPP32 in complex with the tetrapeptide acetyl-Asp-Val-AlaAsp fluoromethyl ketone[J].Journal of Biological Chemistry,1997.6539-6547.
  • 9Ray P,De A,Patel M. Monitoring caspase-3 activation with a multimodality imaging sensor in living subjects[J].Clinical Cancer Research,2008.5801-5809.doi:10.1158/1078-0432.CCR-07-5244.
  • 10Kanno A,Yamanaka Y,Hirano H. Cyclic luciferase for real-time sensing of caspase-3 activities in living mammals[J].Angewandte Chemie International Edition in English,2007.7739-7743.

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部